Literature DB >> 15248229

Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease.

M Ben Ahmed1, H Houman, M Miled, K Dellagi, H Louzir.   

Abstract

OBJECTIVE: To investigate a possible pathogenic role of cytokines in Behçet's disease (BD) by focusing on the analysis of cytokine gene expression within mucocutaneous BD lesions.
METHODS: The study group comprised 20 patients with active BD. In this group, a set of chemokines as well as Th1 and Th2 cytokines in biopsy specimens obtained from oral and genital ulcers, pseudofolliculitis lesions, and lesions at the site of pathergy testing were studied using real-time quantitative reverse transcriptase-polymerase chain reaction.
RESULTS: We observed important increases in the expression of interleukin-8 (IL-8) ( approximately 700-fold), monocyte chemoattractant protein 1 ( approximately 65-fold), interferon-gamma ( approximately 71-fold), and IL-12 ( approximately 69-fold) messenger RNA in BD lesions compared with normal skin. Except for IL-10 ( approximately 75-fold increase), Th2 cytokines (i.e., IL-4 and IL-13) were absent.
CONCLUSION: Our data suggest a direct role of Th1 lymphocytes in the pathogenesis of mucocutaneous BD lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15248229     DOI: 10.1002/art.20334

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  42 in total

Review 1.  Association of cytokine gene polymorphisms (IL‑6, IL‑12B, IL‑18) with Behcet's disease : A meta-analysis.

Authors:  Y Xu; K Zhou; Z Yang; F Li; Z Wang; F Xu; C He
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

2.  Immune and inflammatory gene expressions are different in Behçet's disease compared to those in Familial Mediterranean Fever.

Authors:  Filiz Türe Özdemir; Emel Ekşioğlu Demiralp; Sibel Z Aydın; Pamir Atagündüz; Tülin Ergun; Haner Direskeneli
Journal:  Eur J Rheumatol       Date:  2016-12-01

Review 3.  The unique features of vasculitis in Behçet's syndrome.

Authors:  Melike Melikoglu; Emire Kural-Seyahi; Koray Tascilar; Hasan Yazici
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

4.  Serum IL-4, IL-12, IL-13, IL-27, and IL-33 levels in active and inactive ocular Behcet's disease.

Authors:  Abdullah Kursat Cingu; Fatih Mehmet Turkcu; Serdar Aktas; Alparslan Sahin; Orhan Ayyildiz
Journal:  Int Ophthalmol       Date:  2020-07-29       Impact factor: 2.031

5.  Behçet's disease diagnosed by lower extremity ulcers.

Authors:  Bahar Sevimli Dikicier; Alper Erkin; Büşra Aydın
Journal:  Int Wound J       Date:  2018-09-03       Impact factor: 3.315

6.  Possible association of proinflammatory cytokines including IL1β and TNFα with enhanced Th17 cell differentiation in patients with Behcet's disease.

Authors:  Jun Shimizu; Kenji Takai; Erika Takada; Naruyoshi Fujiwara; Nagisa Arimitsu; Yuji Ueda; Sueshige Wakisaka; Tomoko Suzuki; Noboru Suzuki
Journal:  Clin Rheumatol       Date:  2015-05-14       Impact factor: 2.980

7.  Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.

Authors:  J Shimizu; K Takai; N Fujiwara; N Arimitsu; Y Ueda; S Wakisaka; H Yoshikawa; F Kaneko; T Suzuki; N Suzuki
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

8.  Serum IL-33 level and IL-33 gene polymorphisms in Behçet's disease.

Authors:  Suleyman Serdar Koca; Murat Kara; Firat Deniz; Metin Ozgen; Caner Feyzi Demir; Nevin Ilhan; Ahmet Isik
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

9.  Colchicine modulates oxidative stress in serum and neutrophil of patients with Behçet disease through regulation of Ca²⁺ release and antioxidant system.

Authors:  Selma Korkmaz; Ijlal Erturan; Mustafa Nazıroğlu; Abdulhadi Cihangir Uğuz; Bilal Ciğ; Ishak Suat Övey
Journal:  J Membr Biol       Date:  2011-11-04       Impact factor: 1.843

10.  Natural killer cells control a T-helper 1 response in patients with Behçet's disease.

Authors:  Yukie Yamaguchi; Hayato Takahashi; Takashi Satoh; Yuka Okazaki; Nobuhisa Mizuki; Kazuo Takahashi; Zenro Ikezawa; Masataka Kuwana
Journal:  Arthritis Res Ther       Date:  2010-05-11       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.